Barclays’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.18M | Sell |
50,323
-264,349
| -84% | -$5.74M | ﹤0.01% | 2658 |
|
|
2025
Q4 | $6.61M | Sell |
314,672
-33,389
| -10% | -$582K | ﹤0.01% | 2003 |
|
|
2025
Q3 | $5.35M | Sell |
348,061
-34,905
| -9% | -$457K | ﹤0.01% | 2144 |
|
|
2025
Q2 | $3.59M | Buy |
382,966
+182,977
| +91% | +$2.01M | ﹤0.01% | 2380 |
|
|
2025
Q1 | $2.46M | Buy |
199,989
+3,938
| +2% | +$55.5K | ﹤0.01% | 2474 |
|
|
2024
Q4 | $2.59M | Buy |
196,051
+8,422
| +4% | +$144K | ﹤0.01% | 2696 |
|
|
2024
Q3 | $3.61M | Buy |
187,629
+110,535
| +143% | +$2.28M | ﹤0.01% | 2360 |
|
|
2024
Q2 | $1.58M | Sell |
77,094
-25,078
| -25% | -$525K | ﹤0.01% | 2304 |
|
|
2024
Q1 | $2.43M | Sell |
102,172
-153,705
| -60% | -$3.43M | ﹤0.01% | 2412 |
|
|
2023
Q4 | $5.53M | Sell |
255,877
-166,131
| -39% | -$2.55M | ﹤0.01% | 2003 |
|
|
2023
Q3 | $6.13M | Buy |
422,008
+252,813
| +149% | +$4.78M | ﹤0.01% | 1212 |
|
|
2023
Q2 | $3.54M | Sell |
169,195
-812,691
| -83% | -$16.9M | ﹤0.01% | 1552 |
|
|
2023
Q1 | $20.7M | Buy |
981,886
+18,550
| +2% | +$461K | 0.01% | 826 |
|
|
2022
Q4 | $24.5M | Buy |
963,336
+687,577
| +249% | +$16M | 0.01% | 792 |
|
|
2022
Q3 | $6.63M | Buy |
275,759
+271,168
| +5,907% | +$6.08M | 0.01% | 1022 |
|
|
2022
Q2 | $88K | Sell |
4,591
-69,643
| -94% | -$1.16M | ﹤0.01% | 3823 |
|
|
2022
Q1 | $1.29M | Sell |
74,234
-701,242
| -90% | -$11.8M | ﹤0.01% | 2205 |
|
|
2021
Q4 | $17M | Buy |
775,476
+373,088
| +93% | +$6.89M | 0.01% | 1011 |
|
|
2021
Q3 | $7.69M | Buy |
402,388
+345,050
| +602% | +$5.75M | ﹤0.01% | 1342 |
|
|
2021
Q2 | $984K | Sell |
57,338
-14,821
| -21% | -$271K | ﹤0.01% | 2668 |
|
|
2021
Q1 | $1.61M | Buy |
72,159
+61,976
| +609% | +$1.4M | ﹤0.01% | 2467 |
|
|
2020
Q4 | $226K | Sell |
10,183
-3,061
| -23% | -$63.5K | ﹤0.01% | 3694 |
|
|
2020
Q3 | $196K | Sell |
13,244
-36,404
| -73% | -$555K | ﹤0.01% | 3872 |
|
|
2020
Q2 | $736K | Buy |
49,648
+40,707
| +455% | +$620K | ﹤0.01% | 3021 |
|
|
2020
Q1 | $99K | Sell |
8,941
-16,000
| -64% | -$150K | ﹤0.01% | 4809 |
|
|
2019
Q4 | $218K | Buy |
24,941
+9,997
| +67% | +$73.4K | ﹤0.01% | 4972 |
|
|
2019
Q3 | $111K | Sell |
14,944
-2,881
| -16% | -$26.2K | ﹤0.01% | 5400 |
|
|
2019
Q2 | $167K | Buy |
17,825
+8,603
| +93% | +$62.7K | ﹤0.01% | 5272 |
|
|
2019
Q1 | $48K | Sell |
9,222
-2,630
| -22% | -$15K | ﹤0.01% | 5905 |
|
|
2018
Q4 | $52K | Sell |
11,852
-6,081
| -34% | -$33.3K | ﹤0.01% | 5460 |
|
|
2018
Q3 | $144K | Buy |
17,933
+7,739
| +76% | +$55.2K | ﹤0.01% | 5255 |
|
|
2018
Q2 | $72K | Buy |
10,194
+2,732
| +37% | +$26.8K | ﹤0.01% | 5438 |
|
|
2018
Q1 | $106K | Buy |
7,462
+785
| +12% | +$8.33K | ﹤0.01% | 5341 |
|
|
2017
Q4 | $58K | Sell |
6,677
-7,727
| -54% | -$76.5K | ﹤0.01% | 5663 |
|
|
2017
Q3 | $168K | Buy |
14,404
+9,360
| +186% | +$115K | ﹤0.01% | 4572 |
|
|
2017
Q2 | $70K | Sell |
5,044
-1,067
| -17% | -$12.2K | ﹤0.01% | 5144 |
|
|
2017
Q1 | $83K | Buy |
6,111
+304
| +5% | +$3.16K | ﹤0.01% | 5020 |
|
|
2016
Q4 | $41K | Buy |
5,807
+170
| +3% | +$1.86K | ﹤0.01% | 5289 |
|
|
2016
Q3 | $85K | Buy |
5,637
+4,839
| +606% | +$63.6K | ﹤0.01% | 4619 |
|
|
2016
Q2 | $8K | Buy |
+798
| New | +$10.9K | ﹤0.01% | 5621 |
|
Other funds holding SNDX
KCM
VCM
DM
EP
KCM
HRCM